Fig. 5.
Clinical outcomes according to serum IL-6 at baseline. A) overall survival, B) bone disease progression, from date of bisphosphonates introduction Multivariate analysis controlling for sYB-1.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.